VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. GOOG
6. CSX
7. IBM
8. KNX
9. LVS
10. INTC

Go back to VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
(NASDAQ: VIVS) Delayed: 0.44 -0.02 (4.35%)
Previous Close $0.46    52 Week High $ 
Open $0.45    52 Week Low $ 
Day High $0.46    P/E N/A 
Day Low $0.43    EPS $ 
Volume 612,477